Importantly, since SMYD5 is also elevated in other cancer types (TCGA, Supplementary information, Fig. S1a), future research should focus on developing specific inhibitors or modulators of SMYD5 as a general approach for cancer therapy. This evidence concerns the gene SMYD5 and cancer.